What is the two-person verification rule for high‑risk medications?

What is the two-person verification rule for high‑risk medications?

• A. Two licensed staff independently verify the correct patient, drug, dose, route, time, and allergy status before administration.
• B. Two nurses verify only the patient and drug.
• C. A pharmacist verifies after administration.
• D. Verification is required only for low‑risk medications.

Answer: (A)

The main idea here is patient-safety through an independent double-check for high‑risk medications. Two licensed staff must separately verify before you administer the drug that everything lines up with the order: the patient identity, the drug itself, the exact dose, the route, the scheduled time, and the patient’s allergy status. This two-person, independent review helps catch mistakes that a single clinician might miss, such as giving the wrong drug to the wrong patient, an incorrect dose, or administering a drug to someone with an allergy. Verifying before administration ensures any potential error is caught and corrected before the medicine reaches the patient. It’s not enough to check only the patient and drug, nor to verify after administration, and the rule is specifically for high‑risk meds where the consequence of errors is greatest.

The main idea here is patient-safety through an independent double-check for high‑risk medications. Two licensed staff must separately verify before you administer the drug that everything lines up with the order: the patient identity, the drug itself, the exact dose, the route, the scheduled time, and the patient’s allergy status. This two-person, independent review helps catch mistakes that a single clinician might miss, such as giving the wrong drug to the wrong patient, an incorrect dose, or administering a drug to someone with an allergy. Verifying before administration ensures any potential error is caught and corrected before the medicine reaches the patient. It’s not enough to check only the patient and drug, nor to verify after administration, and the rule is specifically for high‑risk meds where the consequence of errors is greatest.